248 related articles for article (PubMed ID: 31501954)
1. Survival of the fittest: how myeloid-derived suppressor cells survive in the inhospitable tumor microenvironment.
Ostrand-Rosenberg S; Beury DW; Parker KH; Horn LA
Cancer Immunol Immunother; 2020 Feb; 69(2):215-221. PubMed ID: 31501954
[TBL] [Abstract][Full Text] [Related]
2. High-mobility group box protein 1 promotes the survival of myeloid-derived suppressor cells by inducing autophagy.
Parker KH; Horn LA; Ostrand-Rosenberg S
J Leukoc Biol; 2016 Sep; 100(3):463-70. PubMed ID: 26864266
[TBL] [Abstract][Full Text] [Related]
3. Myeloid-Derived Suppressor Cell Survival and Function Are Regulated by the Transcription Factor Nrf2.
Beury DW; Carter KA; Nelson C; Sinha P; Hanson E; Nyandjo M; Fitzgerald PJ; Majeed A; Wali N; Ostrand-Rosenberg S
J Immunol; 2016 Apr; 196(8):3470-8. PubMed ID: 26936880
[TBL] [Abstract][Full Text] [Related]
4. Bio-HMGB1 from breast cancer contributes to M-MDSC differentiation from bone marrow progenitor cells and facilitates conversion of monocytes into MDSC-like cells.
Su Z; Ni P; She P; Liu Y; Richard SA; Xu W; Zhu H; Wang J
Cancer Immunol Immunother; 2017 Mar; 66(3):391-401. PubMed ID: 27987020
[TBL] [Abstract][Full Text] [Related]
5. Calcium/Calmodulin Dependent Protein Kinase Kinase 2 Regulates the Expansion of Tumor-Induced Myeloid-Derived Suppressor Cells.
Huang W; Liu Y; Luz A; Berrong M; Meyer JN; Zou Y; Swann E; Sundaramoorthy P; Kang Y; Jauhari S; Lento W; Chao N; Racioppi L
Front Immunol; 2021; 12():754083. PubMed ID: 34712241
[TBL] [Abstract][Full Text] [Related]
6. Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy.
Hubert P; Roncarati P; Demoulin S; Pilard C; Ancion M; Reynders C; Lerho T; Bruyere D; Lebeau A; Radermecker C; Meunier M; Nokin MJ; Hendrick E; Peulen O; Delvenne P; Herfs M
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33712445
[TBL] [Abstract][Full Text] [Related]
7. HMGB1 enhances immune suppression by facilitating the differentiation and suppressive activity of myeloid-derived suppressor cells.
Parker KH; Sinha P; Horn LA; Clements VK; Yang H; Li J; Tracey KJ; Ostrand-Rosenberg S
Cancer Res; 2014 Oct; 74(20):5723-33. PubMed ID: 25164013
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol ameliorates Lewis lung carcinoma-bearing mice development, decreases granulocytic myeloid-derived suppressor cell accumulation and impairs its suppressive ability.
Zhao Y; Shao Q; Zhu H; Xu H; Long W; Yu B; Zhou L; Xu H; Wu Y; Su Z
Cancer Sci; 2018 Sep; 109(9):2677-2686. PubMed ID: 29959821
[TBL] [Abstract][Full Text] [Related]
9. Roles of HMGB1 in regulating myeloid-derived suppressor cells in the tumor microenvironment.
Jin S; Yang Z; Hao X; Tang W; Ma W; Zong H
Biomark Res; 2020; 8():21. PubMed ID: 32551121
[TBL] [Abstract][Full Text] [Related]
10. Autocrine IL6-Mediated Activation of the STAT3-DNMT Axis Silences the TNFα-RIP1 Necroptosis Pathway to Sustain Survival and Accumulation of Myeloid-Derived Suppressor Cells.
Smith AD; Lu C; Payne D; Paschall AV; Klement JD; Redd PS; Ibrahim ML; Yang D; Han Q; Liu Z; Shi H; Hartney TJ; Nayak-Kapoor A; Liu K
Cancer Res; 2020 Aug; 80(15):3145-3156. PubMed ID: 32554751
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress-dependent contribution of HMGB1 to the interplay between apoptosis and autophagy in diabetic rat liver.
Petrović A; Bogojević D; Korać A; Golić I; Jovanović-Stojanov S; Martinović V; Ivanović-Matić S; Stevanović J; Poznanović G; Grigorov I
J Physiol Biochem; 2017 Nov; 73(4):511-521. PubMed ID: 28695466
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of autophagy mediators in myeloid-derived suppressor cells during human tuberculosis.
Kotze LA; Leukes VN; Fang Z; Lutz MB; Fitzgerald BL; Belisle J; Loxton AG; Walzl G; du Plessis N
Cell Immunol; 2021 Nov; 369():104426. PubMed ID: 34469846
[TBL] [Abstract][Full Text] [Related]
13. PMN-MDSCs Enhance CTC Metastatic Properties through Reciprocal Interactions via ROS/Notch/Nodal Signaling.
Sprouse ML; Welte T; Boral D; Liu HN; Yin W; Vishnoi M; Goswami-Sewell D; Li L; Pei G; Jia P; Glitza-Oliva IC; Marchetti D
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003475
[TBL] [Abstract][Full Text] [Related]
14. Ceramide activates lysosomal cathepsin B and cathepsin D to attenuate autophagy and induces ER stress to suppress myeloid-derived suppressor cells.
Liu F; Li X; Lu C; Bai A; Bielawski J; Bielawska A; Marshall B; Schoenlein PV; Lebedyeva IO; Liu K
Oncotarget; 2016 Dec; 7(51):83907-83925. PubMed ID: 27880732
[TBL] [Abstract][Full Text] [Related]
15. The immune suppressive tumor microenvironment in multiple myeloma: The contribution of myeloid-derived suppressor cells.
Giannotta C; Autino F; Massaia M
Front Immunol; 2022; 13():1102471. PubMed ID: 36726975
[TBL] [Abstract][Full Text] [Related]
16. Concerted action of Nrf2-ARE pathway, MRN complex, HMGB1 and inflammatory cytokines - implication in modification of radiation damage.
Anuranjani ; Bala M
Redox Biol; 2014; 2():832-46. PubMed ID: 25009785
[TBL] [Abstract][Full Text] [Related]
17. Asah2 Represses the p53-Hmox1 Axis to Protect Myeloid-Derived Suppressor Cells from Ferroptosis.
Zhu H; Klement JD; Lu C; Redd PS; Yang D; Smith AD; Poschel DB; Zou J; Liu D; Wang PG; Ostrov D; Coant N; Hannun YA; Colby AH; Grinstaff MW; Liu K
J Immunol; 2021 Mar; 206(6):1395-1404. PubMed ID: 33547170
[TBL] [Abstract][Full Text] [Related]
18. Activation of autophagy and suppression of apoptosis by dapagliflozin attenuates experimental inflammatory bowel disease in rats: Targeting AMPK/mTOR, HMGB1/RAGE and Nrf2/HO-1 pathways.
Arab HH; Al-Shorbagy MY; Saad MA
Chem Biol Interact; 2021 Feb; 335():109368. PubMed ID: 33412153
[TBL] [Abstract][Full Text] [Related]
19. HMGB1 deficiency reduces H
Mou K; Liu W; Miao Y; Cao F; Li P
J Cell Mol Med; 2018 Dec; 22(12):6148-6156. PubMed ID: 30338917
[TBL] [Abstract][Full Text] [Related]
20. Myeloid-Derived Suppressor Cells Are a Major Source of Wnt5A in the Melanoma Microenvironment and Depend on Wnt5A for Full Suppressive Activity.
Douglass SM; Fane ME; Sanseviero E; Ecker BL; Kugel CH; Behera R; Kumar V; Tcyganov EN; Yin X; Liu Q; Chhabra Y; Alicea GM; Kuruvilla R; Gabrilovich DI; Weeraratna AT
Cancer Res; 2021 Feb; 81(3):658-670. PubMed ID: 33262126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
